查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363199

细胞计数市场规模、份额和趋势分析报告：按产品、用途、最终用途、地区和细分市场进行预测，2023-2030 年

Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Complete Blood Count, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

细胞计数市场成长与趋势：

Grand View Research, Inc.最新报告显示，2023年至2030年，全球细胞计数市场规模预计将以8.2%的年复合成长率成长，2030年达到154.6亿美元。

癌症、爱滋病毒和阿兹海默症等慢性疾病盛行率的上升正在推动该行业的成长。这些疾病的日益普及正在推动临床研究活动的激增，从而导致对细胞计数设备和消耗品的需求激增。政府推动细胞治疗药物开发的配合措施也在扩大市场成长前景，其中细胞计数在其中发挥关键作用。

成长主要是由于研究机构与各种公共和私人组织之间越来越多的合作来促进研究和发展。在未来年度中，我们将看到越来越多的指南和建议被提案给公共和私人实验室，以确保高品质标准并促进准确结果的产生。这可能会提高设备的采用率。例如，2021 年 5 月，国际干细胞协会更新了细胞治疗和研发指南。提案的指南将重点关注研发的各个阶段，并提高临床前研究的品质。

这些设备的技术进步也扩大了市场的成长前景。分化细胞计数的一项有前途的技术进展是能够以更高的精度执行原始细胞识别、免疫血小板计数、原始细胞检测、网状红血球分级分离和干细胞计数。 CD4+T 细胞计数技术的出现已被证明作为免疫反应的指标非常有用，并已用于评估抗逆转录病毒病毒治疗 (ARV) 的成功或失败。市面上有专用用于计数 CD4+ 和 CD8+ T 细胞的细胞仪，例如 Becton Dickinson 的 FACSCount，它是基于 T 细胞计数技术。

COVID-19 大流行预计将对行业成长产生积极影响。住院 COVID-19 患者的 WBC 计数与患者死亡率有显着相关。白血球数越高，越应重视COVID-19的治疗。细胞计数对于罹患的患者的重要性日益增加，促进了该行业在大流行期间的成长。

增强型资讯科学解决方案和改进的影像分析仪器（如光学和萤光显微镜）的市场开拓正在推动该市场的成长前景。这些仪器越来越多地在新兴经济体中常见的低试样处理通量实验室和资源有限的环境中被采用，从而扩大了该行业的成长范围。

另一方面，熟练专业人员数量有限是限制市场成长的重要因素。熟练专业人员的短缺是由于缺乏培训设施和高昂的培训成本。为了改善这种情况，敦促行业公司参与为这些公司开发的软体创建培训计划，并鼓励医疗保健专业人员和研究人员操作细胞计数软体。此外，这些软体工具缺乏标准化也对研究人员和医疗保健专业人员产生了重大限制，因为每个软体都有不同的使用者介面。

细胞计数市场报告亮点

  • 按产品划分，消耗品及配件领域预计将在 2022 年占据最大的收益占有率，达到 54.14%，并在预测期内以 8.4% 的年复合成长率增长最快。
  • 在消耗品及配件领域，试剂占2022年最大的收益占有率，为56.3%。这一巨大的收益占有率是由重复购买这些用于光强度、流式细胞仪和自动细胞计数的产品所推动的。
  • 预计微孔板细分市场在预测期内将以最快的年复合成长率扩张。微孔板通常用于分析浓度非常低的样品。由于在分析新样品时需要重复使用新板以防止污染，微孔板的消耗量不断增加。
  • 在设备领域，自动细胞计数器预计在预测期内将出现指数级增长。由于检查时间更短、错误率更低以及操作员之间的差异等优点，对自动化计数器的需求预计将进一步增加。
  • 按用途来看，全血球计数领域占最大收益占有率， 2022年将达59.1%。如此大的收益占有率是由于血液疾病的发生率不断增加。
  • 在最终用途领域，由于政府措施促进各种毒理学研究的研发，研究和学术机构在 2022 年占据了最大的收益占有率，达到 39.6%。
  • 预计製药和生物技术公司在预测期内将以 9.0% 的年复合成长率实现最快成长。
  • 由于对医学和癌症研究的日益关注，北美地区占据了最大的收益占有率，超过 37.6%。
  • 由于众多临床研究机构和生物製药公司的存在，预计亚太地区在预测期内将以 10.3% 的年复合成长率快速成长。

目录

第1章调查方法与范围

第2章执行摘要

第3章细胞计数市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 细胞计数市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章细胞计数市场：依产品类型估算与趋势分析

  • 细胞计数市场：要点
  • 细胞计数市场：2022 年和 2030 年趋势和市场占有率分析
  • 装置
  • 消耗品及配件

第5章细胞计数市场：按用途估算和趋势分析

  • 细胞计数市场：要点
  • 细胞计数市场：2022 年和 2030 年趋势和市场占有率分析
  • 血液常规检查
  • 干细胞研究
  • 细胞疗法
  • 生物加工
  • 毒理学
  • 其他的

第6章细胞计数市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的细胞计数市场：主要市场要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • ThermoFisher Scientific, Inc
    • Merck KGaA
    • Agilent Technologies
    • PerkinElmer, Inc
    • BD
    • Danaher
    • Bio-Rad Laboratories, Inc
    • BioTek Instruments, Inc
    • GE Healthcare
    • DeNovix Inc
Product Code: GVR-1-68038-592-2

Cell Counting Market Growth & Trends:

The global cell counting market size is expected to reach USD 15.46 billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer's is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.

An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to growth. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.

Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.

The COVID-19 pandemic is anticipated to positively impact industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.

The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled the growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.

On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to a lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, the lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differ in user interface.

Cell Counting Market Report Highlights:

  • By product, consumables and accessories segment accounted for the largest revenue share of 54.14% in 2022 and is expected to grow at the fastest CAGR of 8.4% over the forecast period
  • In the consumables and accessories segment, reagents held the largest revenue share of 56.3% in 2022. The large revenue share is attributed to the repeat purchase of these products for use during spectrophotometry, flow cytometry, and automated cell counting
  • The microplates sub-segment is poised to expand at the fastest CAGR during the forecast period. Microplates are usually used for analyzing very low concentration samples. The increased consumption of these plates is attributed to the repeated need to use fresh plates for analyzing a new sample to prevent contamination
  • In the instruments segment, automated cell counters are anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and inter-operator variability are expected to further increase the demand for automated counters
  • By application, the complete blood count segment held the largest revenue share of 59.1% in 2022. The large revenue share can be attributed to increasing incidence of blood disorders
  • In the end-use segment, research and academic institutes accounted for the largest revenue share of 39.6% in2022 owing to growing number of government initiatives focused on promoting R&D in various toxicology studies
  • Pharmaceutical and biotechnology companies are anticipated to grow at the fastest CAGR of 9.0% during the forecast period
  • North America held the largest revenue share of over 37.6% owing to the increasing focus on biomedical and cancer research
  • Asia Pacific is expected to grow at the fastest CAGR of 10.3% over the forecast period owing to the large presence of clinical research organizations and biopharmaceutical companies in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Counting Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Cell Counting Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic Landscape

Chapter 4. Cell Counting Market: Product Type Estimates & Trend Analysis

  • 4.1. Cell Counting Market: Key Takeaways
  • 4.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Spectrophotometers
      • 4.3.2.1. Spectrophotometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Flow cytometers
      • 4.3.3.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Hemocytometers
      • 4.3.4.1. Hemocytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Automated cell counters
      • 4.3.5.1. Automated cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Microscopes
      • 4.3.6.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumable & Accessories
      • 4.4.1.1. Consumable & Accessories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Reagents
      • 4.4.2.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Microplates
      • 4.4.3.1. Microplates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell Counting Market: Application Estimates & Trend Analysis

  • 5.1. Cell Counting Market: Key Takeaways
  • 5.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Complete Blood Count
    • 5.3.1. Complete blood count market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Stem Cell Research
    • 5.4.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cell-Based Therapeutics
    • 5.5.1. Cell-based therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Bioprocessing
    • 5.6.1. Bioprocessing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Toxicology
    • 5.7.1. Toxicology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell Counting Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Cell Counting Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. U.K.
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. ThermoFisher Scientific, Inc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Merck KGaA
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Agilent Technologies
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. PerkinElmer, Inc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BD
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Danaher
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Bio-Rad Laboratories, Inc
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. BioTek Instruments, Inc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. GE Healthcare
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. DeNovix Inc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 23 France cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 24 France cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 44 China cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 45 China cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 46 China cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 51 India cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 52 India cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Latin America cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Mexico cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Argentina cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 UAE cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 83 UAE cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait cell counting market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cell counting: Market outlook
  • Fig. 9 Cell counting: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cell counting market driver impact
  • Fig. 15 Cell counting market restraint impact
  • Fig. 16 Cell counting market strategic initiatives analysis
  • Fig. 17 Cell counting market: Product type movement analysis
  • Fig. 18 Cell counting market: Product type outlook and key takeaways
  • Fig. 19 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 20 Consumables & accessories market estimates and forecasts, 2018 - 2030
  • Fig. 21 Cell counting market: Application movement analysis
  • Fig. 22 Cell counting market: Application outlook and key takeaways
  • Fig. 23 Complete blood count market estimates and forecasts, 2018 - 2030
  • Fig. 24 Stem cell research market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cell-based therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 26 Bioprocessing market estimates and forecasts, 2018 - 2030
  • Fig. 27 Toxicology market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 Cell counting market: End-use movement analysis
  • Fig. 30 Cell counting market: End-use outlook and key takeaways
  • Fig. 31 Hospitals & diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Research & academic Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 33 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global cell counting market: Regional movement analysis
  • Fig. 36 Global cell counting market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 43 France market estimates and forecasts, 2018 - 2030
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 47 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 50 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 51 China market estimates and forecasts, 2018 - 2030
  • Fig. 52 India market estimates and forecasts, 2018 - 2030
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030